Latest news
Treating hypertension in pregnancy is possible. Making it routine care is the policy challenge
A new ACC expert analysis sets out a practical approach to antihypertensive medication use in pregnancy and lactation, naming extended-release nifedipine and labetalol as preferred options in pregnancy, and nifedipine, amlodipine, enalapril and labetalol as preferred options during lactation. The clinical message is clear. The policy message is bigger: pregnant and postpartum patients need safe…
WHO is preparing to ration the obesity drug revolution before it becomes another access disaster
CAR-T Starts Moving From Factory Medicine to In-Patient Engineering
AML’s Frontline Future Starts With Finding the Mutation Fast
FSHD Gets a Stronger Biological Signal
ALS Immunotherapy Moves Into the Extension Phase
Measles Deaths in England Expose the Cost of Missed Protection
Europe’s AMR Strategy Depends on the Lab Result Being Right
Heatwaves are emerging as a cardiovascular risk factor, prompting calls for stronger climate adaptation and public health policies
Eli Lilly’s retatrutide could reset obesity care, but rising demand and grey-market access are testing regulators and health systems
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.